Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Johnson & Johnson Vaccine for COVID-19.

Literature DB >> 33646285

The Johnson & Johnson Vaccine for COVID-19.

Edward H Livingston¹, Preeti N Malani², C Buddy Creech³.

Abstract

Entities: Disease

Year: 2021 PMID： 33646285 DOI： 10.1001/jama.2021.2927

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

56 in total

Review 1. Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

Authors: Hayder M Al-Kuraishy; Ali I Al-Gareeb; Sadiq M Al-Hamash; Simona Cavalu; Maisra M El-Bouseary; Fatma I Sonbol; Gaber El-Saber Batiha
Journal: Front Med (Lausanne) Date: 2022-06-17

2. Non-iterative learning machine for identifying CoViD19 using chest X-ray images.

Authors: Sahil Dalal; Virendra P Vishwakarma; Varsha Sisaudia; Parul Narwal
Journal: Sci Rep Date: 2022-07-13 Impact factor: 4.996

3. Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.

Authors: Nusrat J Epsi; Stephanie A Richard; David A Lindholm; Katrin Mende; Anuradha Ganesan; Nikhil Huprikar; Tahaniyat Lalani; Anthony C Fries; Ryan C Maves; Rhonda E Colombo; Derek T Larson; Alfred Smith; Sharon W Chi; Carlos J Maldonado; Evan C Ewers; Milissa U Jones; Catherine M Berjohn; Daniel H Libraty; Margaret Sanchez Edwards; Caroline English; Julia S Rozman; Rupal M Mody; Christopher J Colombo; Emily C Samuels; Princess Nwachukwu; Marana S Tso; Ann I Scher; Celia Byrne; Jennifer Rusiecki; Mark P Simons; David Tribble; Christopher C Broder; Brian K Agan; Timothy H Burgess; Eric D Laing; Simon D Pollett
Journal: Clin Infect Dis Date: 2022-05-24 Impact factor: 20.999

The Johnson & Johnson Vaccine for COVID-19.

Review 1. Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

2. Non-iterative learning machine for identifying CoViD19 using chest X-ray images.

3. Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.

4. Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020.

Review 5. Flavonoids are promising safe therapy against COVID-19.

Review 6. Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment.

7. Protein Based Biomaterials for Therapeutic and Diagnostic Applications.

8. The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL^pro In Vitro.

Review 9. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.

Review 10. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development.

The Johnson & Johnson Vaccine for COVID-19.

Review 1. Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

2. Non-iterative learning machine for identifying CoViD19 using chest X-ray images.

3. Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.

4. Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020.

Review 5. Flavonoids are promising safe therapy against COVID-19.

Review 6. Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment.

7. Protein Based Biomaterials for Therapeutic and Diagnostic Applications.

8. The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro.

Review 9. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.

Review 10. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development.

8. The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL^pro In Vitro.